TC BioPharm (Holdings) plc American Depositary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
TCBP Company Description
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
TCBP Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view TCBP Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of TCBP by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TCBP's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of TCBP in WallStreetBets Daily Discussion
TCBP News
Recent insights relating to TCBP
CNBC Recommendations
Recent picks made for TCBP stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in TCBP
Corporate Flights
Flights by private jets registered to TCBP
Our Analysis